MEI Pharma, Inc.
Institutional Ownership & Holdings Analysis
About
mei-pharma is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | Anson Funds Management LP(2025-03-31) | $2.4M |
2 | Cable Car Capital, LP(2025-03-31) | $1.3M |
3 | VANGUARD GROUP INC(2025-03-31) | $880.9K |
4 | RENAISSANCE TECHNOLOGIES LLC(2025-03-31) | $294.4K |
5 | ACADIAN ASSET MANAGEMENT LLC(2025-03-31) | $209.0K |
6 | BlackRock, Inc.(2025-03-31) | $145.6K |
7 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $126.5K |
8 | CITADEL ADVISORS LLC(2025-03-31) | $81.3K |
9 | MACQUARIE GROUP LTD(2025-03-31) | $66.0K |
10 | BRIDGEWAY CAPITAL MANAGEMENT, LLC(2025-03-31) | $58.8K |
11 | TORONTO DOMINION BANK(2025-03-31) | $54.8K |
12 | DIMENSIONAL FUND ADVISORS LP(2025-03-31) | $51.3K |
13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP(2025-03-31) | $41.8K |
14 | STATE STREET CORP(2025-03-31) | $39.0K |
15 | Virtu Financial LLC(2024-12-31) | $26.0K |
16 | NORTHERN TRUST CORP(2025-03-31) | $23.1K |
17 | UBS Group AG(2025-03-31) | $14.1K |
18 | MORGAN STANLEY(2025-03-31) | $12.8K |
19 | Newbridge Financial Services Group, Inc.(2025-03-31) | $4.4K |
20 | Tower Research Capital LLC (TRC)(2025-03-31) | $3.4K |
As of 2025-03-31
Value:$2.4M
As of 2025-03-31
Value:$1.3M
As of 2025-03-31
Value:$880.9K
As of 2025-03-31
Value:$294.4K
As of 2025-03-31
Value:$209.0K
As of 2025-03-31
Value:$145.6K
As of 2025-03-31
Value:$126.5K
As of 2025-03-31
Value:$81.3K
As of 2025-03-31
Value:$66.0K
As of 2025-03-31
Value:$58.8K
As of 2025-03-31
Value:$54.8K
As of 2025-03-31
Value:$51.3K
As of 2025-03-31
Value:$41.8K
As of 2025-03-31
Value:$39.0K
As of 2024-12-31
Value:$26.0K
As of 2025-03-31
Value:$23.1K
#17UBS Group AG
As of 2025-03-31
Value:$14.1K
As of 2025-03-31
Value:$12.8K
As of 2025-03-31
Value:$4.4K
As of 2025-03-31
Value:$3.4K
Total Institutional Holders:34
Top 10 Holders Own:95.3%